Expression profiles of EGFR, c-Met, and mTOR/Wnt alternative signaling pathway proteins in non-small cell lung cancer

被引：0
|
作者：
Shearrow, Caleb [1 ]
Crees, Zachary [1 ]
Girard, Jennifer [1 ]
Harrington, Kymberly [1 ]
Arasi, Kavin [1 ]
Bertram, Ceyda [2 ]
Nowak, Andrew [1 ]
Lin, Leo [1 ]
Sheu, Bonnie [1 ]
Palani, Sunil [1 ]
Puri, Neelu [1 ]
机构：
[1] Univ Illinois, Coll Med Rockford, Rockford, IL USA
[2] Rensselaer Polytech Inst, Albany, NY USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-743
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
743
引用
收藏
页数：2
相关论文
共 50 条
  • [41] HER3 and c-Met Co-Expression in Non-Small and Small Cell Lung Cancers
    Li, M.
    Song, J.
    Faoro, L.
    Tretiakova, M.
    Salgia, R.
    Krausz, T.
    Husain, A. N.
    LABORATORY INVESTIGATION, 2009, 89 : 356A - 356A
  • [42] Deoxybouvardin targets EGFR, MET, and AKT signaling to suppress non-small cell lung cancer cells
    Nam, A-Young
    Joo, Sang Hoon
    Khong, Quan T.
    Park, Jisu
    Lee, Na Yeong
    Lee, Seung-On
    Yoon, Goo
    Park, Jin Woo
    Na, Minkyun
    Shim, Jung-Hyun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [43] A c-met inhibitor in the treatment of metastatic non small cell lung cancer with c-met amplification.
    Zhang, Tongtong
    Li, Junling
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway
    Li, Wei
    Yu, Xinfang
    Tan, Shiming
    Liu, Wenbin
    Zhou, Li
    Liu, Haidan
    CANCER MEDICINE, 2018, 7 (01): : 208 - 218
  • [45] MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis
    Liang, Hongge
    Wang, Mengzhao
    ONCOTARGETS AND THERAPY, 2020, 13 : 2491 - 2510
  • [46] Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancer
    Gao, Hong-Fei
    Yang, Jin-Ji
    Chen, Zhi-Hong
    Zhang, Xu-Chao
    Yan, Hong-Hong
    Guo, Wei-Bang
    Zhou, Qing
    Gou, Lou-Ying
    Dong, Zhong-Yi
    Wu, Yi-Long
    ONCOTARGET, 2016, 7 (26) : 39535 - 39543
  • [47] MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer
    Zhen, Qiang
    Liu, Junfeng
    Gao, Lina
    Liu, Jiabao
    Wang, Renfeng
    Chu, Weiwei
    Zhang, Yaxiao
    Tan, Guoliang
    Zhao, Xiaojian
    Lv, Baolei
    CYTOGENETIC AND GENOME RESEARCH, 2015, 146 (01) : 1 - 8
  • [48] Is EGFR expression important in non-small cell lung cancer?
    Lee, SM
    THORAX, 2006, 61 (02) : 98 - 99
  • [49] Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
    Lixia Ju
    Caicun Zhou
    Cancer Cell International, 13
  • [50] Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
    Botting, Gregory M.
    Rastogi, Ichwaku
    Chhabra, Gagan
    Nlend, Marie
    Puri, Neelu
    PLOS ONE, 2015, 10 (08):
12345